Political Economist

Top Menu

  • Home
  • About us
  • Contact us

Main Menu

  • Local News
  • World News
  • Business & Economy
  • Sports
  • Commentaries
  • Home
  • About us
  • Contact us

logo



Political Economist

  • Local News
  • World News
  • Business & Economy
  • Sports
  • Commentaries
  • Power transmission hits peak of 5,615.40MW; no improvement in supply – consumers

  • Oil industry losing investments to non-passage of PIB – Okowa

  • Osinbajo commends UBA, First Bank, Sterling, Fidelity Bank for leading off-grid financing in Nigeria

  • New Dawn as Sarki Auwalu Stirs Transparency at DPR

  • NAF Plane Crash: Safety Of Nigerian Airspace Remains A Priority – Buhari Mourns Victims

World News
Home›World News›Putin says Russia is first country to approve a COVID-19 vaccine

Putin says Russia is first country to approve a COVID-19 vaccine

By Admin
August 11, 2020
462
0
Putin

Russian President, Vladimir Putin

President Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess.

The vaccine still has to complete final trials, raising concerns among some experts at the speed of its approval, but the Russian business conglomerate Sistema has said it expects to put it into mass production by the end of the year.

Russian health workers treating COVID-19 patients will be offered the chance of volunteering to be vaccinated in the coming weeks, a source told Reuters last month.

Regulatory approval paves the way for the mass inoculation of the Russian population and authorities hope it will allow the economy, which has been battered by fallout from the virus, to return to full capacity.

Kirill Dmitriev, head of Russia’s sovereign wealth fund, hailed the development as a historic “Sputnik moment”, comparable to the Soviet Union’s 1957 launch of Sputnik 1, the world’s first satellite.

The vaccine will be marketed under the name ‘Sputnik V’ on foreign markets, he said.

Dmitriev said Russia had already received foreign requests for 1 billion doses. International agreements had been secured to produce 500 million doses annually, with the vaccine also expected to be produced in Brazil.

He said clinical trials were expected to start soon in the United Arab Emirates and the Philippines.

But only about 10% of clinical trial are successful, and the speed at which Russia has moved, approving a vaccine before the final stages of trials to test safety and efficacy are over, has worried some scientists, who fear Moscow may be putting national prestige before safety.

Speaking at a government meeting on state television, Putin dismissed those concerns, saying the vaccine, developed by Moscow’s Gamaleya Institute, was safe and that it had even been administered to one of his daughters.

“I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks,” said Putin.

He said he hoped mass production would start soon.

The vaccine’s approval by the health ministry comes before the start of a larger trial involving thousands of participants, commonly known as a Phase III trial.

Such trials, which require a certain rate of participants catching the virus to observe the vaccine’s effect, are normally considered essential precursors for a vaccine to receive regulatory approval.

The Moscow-based Association of Clinical Trials Organizations (ACTO), a trade body representing the world’s top drug makers in Russia this week urged the health ministry to postpone approval until that final trial had been successfully completed.

In a letter to the ministry, it said there were high risks associated with registering a drug before that happened.

“It is during this phase that the main evidence of a vaccine’s efficacy is collected, as well as information on adverse reactions that could appear in certain groups of patients: people with weakened immunity, people with concomitant diseases and so forth,” it said.

Some international experts have also questioned the speed at which Russia approved its vaccine.

“Normally you need a large number of people to be tested before you approve a vaccine,” said Peter Kremsner from the University Hospital in Tuebingen, currently testing CureVac’s COVID-19 vaccine in clinical trials.

“In that respect, I think it’s reckless to do that (approve it) if lots of people haven’t already been tested.”

Putin

COVID-19: Race for Vaccine

Duncan Matthews, a professor of intellectual property law at Queen Mary University of London, said news of a potential COVID-19 vaccine was to be welcomed, “but safety must be the priority”.

“The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have fast-track approval procedures for emergency humanitarian use and we need to see evidence that Russia is adopting an equally prudent approach,” Matthews said in an emailed comment.

More than 100 possible vaccines are being developed around the world to try to stop the COVID-19 pandemic. At least four are in final Phase III human trials, according to WHO data.

REUTERS

TagsEMAFDAGamaleya InstituteKirill DmitrievUAEVladimir PutinWHO
Previous Article

France to step up security for its ...

Next Article

NECO unveils timetable, guidelines for 2020 exams

Related articles More from author

  • Breaking NewsWorld News

    Trump cutting U.S. ties with WHO over coronavirus handling

    May 30, 2020
    By Admin
  • U.S.
    Local News

    Beware of toxic hand sanitisers on sale – U.S. agency warns

    August 14, 2020
    By Admin
  • Local News

    Measles: 45 million children in Africa, Asia to receive immunisation 

    February 5, 2020
    By Admin
  • Local News

    One in Every Four Vendors Sold Cigarettes, Tobacco to People Under 18 – FMoH

    February 7, 2019
    By Admin
  • WHO
    Local News

    COVID-19: WHO says over 1,400 health facilities under surveillance in Lagos by its officers

    August 8, 2020
    By Admin
  • Senate
    Local News

    WHO: Trump’s decision will affect Africa in the fight against COVID-19 – NIMR DG

    April 16, 2020
    By Admin

You may be interested

  • SERAP
    Breaking NewsLocal News

    President Buhari signs proclamation order on management of COVID-19 in Lagos, Ogun, Kano, FCT, other States

  • Local News

    Ibidun Ighodalo: Nigerians call for investigation

  • World News

    Mob kills DJ for playing ‘boring music’

Fidelity Advert
  • LATEST REVIEWS

  • TOP REVIEWS

  • NDIC Pays N1.45bn to Over 16,000 Depositors of 34 Closed DMBs in 2017– Report

    0
  • Gboko killings: Police DPO under interrogation, others arrested —CP

  • NSE market indices drop by 1.64% after Christmas holidays

    0

    Timeline

    • March 3, 2021

      LASG says LCC will not resume tolling soon

    • March 3, 2021

      LASG says LCC will not resume rolling soon

    • March 3, 2021

      Do not panic, food security guaranteed- LASG assures Lagosians

    • March 3, 2021

      LSPWC COMPLETES REHABILITATION OF OJO DRIVE TO ALABA INTERNATIONAL MARKET, OTHERS

    • March 3, 2021

      FG, OCP of Morocco sign $1.4bn agreement on gas industrialisation

    Latest Comments

    • Justopec
      on
      April 24, 2017
      Good one for the NPF.

      Police foil another suicide bomb attempt in Borno, kill three bombers

    • Justice Shedrack
      on
      April 24, 2017
      Nice

      Police foil another suicide bomb attempt in Borno, kill three bombers

    • Anonymouse
      on
      February 8, 2017
      This is nice...

      Qatar Airways makes history, completes first longest non-stop flight of 16 hours from Doha to New ...

    • Justice Shedrack
      on
      January 19, 2017
      Na wa ooooo

      Confusion in Gambia, Jammeh stays put, Barrow to be sworn in at Gambia embassy in Senegal

    • Taje
      on
      November 10, 2016
      It's true. Debrecen looks like africa and not europe. Too much "blackness"

      Exclusive: Nigeria Has Highest Number of International Students in Hungarian University, Says Ambassador Yunusa

    logo

    Political Economist is a liberal news magazine with global affiliations.

    We promote free enterprise and act as a catalyst for the growth of knowledge economy. We are proudly pan-Nigeria yet richly spiced with African and global news. We offer a fair and balanced news reportage presented by our team of well-heeled professional journalists...

    About us

    • 5 Olutosin Ajayi Street, By CPM Church, Ajao Estate, Lagos State, Nigeria
    • +234 805 680 1124
    • info@politicaleconomistng.com
    • Recent

    • Popular

    • Comments

    • LASG says LCC will not resume tolling soon

      By Admin
      March 3, 2021
    • LASG says LCC will not resume rolling soon

      By Admin
      March 3, 2021
    • LASUBEB

      Do not panic, food security guaranteed- LASG assures Lagosians

      By Admin
      March 3, 2021
    • LASUBEB

      LSPWC COMPLETES REHABILITATION OF OJO DRIVE TO ALABA INTERNATIONAL MARKET, OTHERS

      By Admin
      March 3, 2021
    • Jonathan Sacks IGP Abba, Appoints Arase

      By Admin
      April 21, 2015
    • Zinox iPower Inverter Claws to Market Dominance

      By Admin
      November 24, 2014
    • Police foil another suicide bomb attempt in Borno, kill three bombers

      By Admin
      April 24, 2017
    • Your Kidney is Your Life, Watch Your Lifestyle, Counsels Dr. Amira

      By Admin
      February 27, 2015
    • Justopec
      on
      April 24, 2017

      Police foil another suicide bomb attempt in Borno, kill three bombers

      Good one for the ...
    • Justice Shedrack
      on
      April 24, 2017

      Police foil another suicide bomb attempt in Borno, kill three bombers

      Nice
    • Anonymouse
      on
      February 8, 2017

      Qatar Airways makes history, completes first longest non-stop flight of 16 hours from Doha to New ...

      This is nice...
    • Justice Shedrack
      on
      January 19, 2017

      Confusion in Gambia, Jammeh stays put, Barrow to be sworn in at Gambia embassy in Senegal

      Na wa ooooo

    Find us on Facebook

    Follow us

    • Home
    • About us
    • Contact us
    • Privacy Policy
    © Copyright Political Economist. All rights reserved.